Articles from Inherent Biosciences Inc

Path Fertility Awarded $2 Million NIH Grant to Develop Epigenetic Test for Severe Male Infertility and Associated Cancer Risk

Company also presents new data at ASRM 2026 showing sperm epigenetics predicts IUI success across clinics and physicians, and that sperm-derived cell-free DNA predicts sperm retrieval outcomes in men with azoospermia

By Inherent Biosciences Inc · Via ACCESS Newswire · October 26, 2026